UNSPSC 51261601: Phenoxybenzamine

This classification denotes a carcinogenic aromatic amine and alpha-adrenergic blocking agent with the molecular formula C18H22ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0TTZ664R7Z, chemically known as n-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzylamine, hydrochloride but generally known as phenoxybenzamine, which bears US NIH Compound Identifier 4768. European Medicines Agency schedules Phenoxybenzamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09778MIG.

UNSPSC 51261601 Phenoxybenzamine is a Commodity code that in practice covers pharmaceutical and medical-supply procurement by state and local health departments and county public-health agencies. The single recent opportunity on record—Seminole County, Florida's IFB for naloxone and drug deactivation systems—suggests the code is being applied to emergency-response and community health supply chains rather than to phenoxybenzamine specifically, indicating either a data-tagging inconsistency or a broader interpretation of the code to encompass life-safety pharmaceuticals and related medical devices used in overdose response and harm-reduction initiatives.

Seminole County's June 2026 IFB (60459723LAS, due July 26, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required E-Verify compliance, drug-free workplace certification, standard liability insurance, and compliance with federal environmental regulations due to potential FEMA funding. The contract term was two years with a one-year renewal option, awarded on a fixed-fee basis. The sourcing data is too sparse to characterize geographic spread or a mix of issuing bodies; the code shows minimal recent state and local activity, and the available record does not align cleanly with the code's nominal pharmaceutical scope.